AU2011324996B2 - Peg or peg block copolymers for treating colorectal cancer - Google Patents

Peg or peg block copolymers for treating colorectal cancer Download PDF

Info

Publication number
AU2011324996B2
AU2011324996B2 AU2011324996A AU2011324996A AU2011324996B2 AU 2011324996 B2 AU2011324996 B2 AU 2011324996B2 AU 2011324996 A AU2011324996 A AU 2011324996A AU 2011324996 A AU2011324996 A AU 2011324996A AU 2011324996 B2 AU2011324996 B2 AU 2011324996B2
Authority
AU
Australia
Prior art keywords
peg
grams
composition
crc
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011324996A
Other languages
English (en)
Other versions
AU2011324996A1 (en
Inventor
Rachel Charlton
Ian Cox
Corinne De Vries
Leighton Jones
Jorg Plessl
Samuel Smith
Peter Stein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norgine BV
Original Assignee
Norgine BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine BV filed Critical Norgine BV
Publication of AU2011324996A1 publication Critical patent/AU2011324996A1/en
Application granted granted Critical
Publication of AU2011324996B2 publication Critical patent/AU2011324996B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AU2011324996A 2010-11-04 2011-11-04 Peg or peg block copolymers for treating colorectal cancer Ceased AU2011324996B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1018650.0A GB201018650D0 (en) 2010-11-04 2010-11-04 Methods and compositions
GB1018650.0 2010-11-04
US41212810P 2010-11-10 2010-11-10
US61/412,128 2010-11-10
PCT/GB2011/001561 WO2012059725A1 (en) 2010-11-04 2011-11-04 Peg or peg block copolymers for treating colorectal cancer

Publications (2)

Publication Number Publication Date
AU2011324996A1 AU2011324996A1 (en) 2013-05-02
AU2011324996B2 true AU2011324996B2 (en) 2015-10-08

Family

ID=43414365

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011324996A Ceased AU2011324996B2 (en) 2010-11-04 2011-11-04 Peg or peg block copolymers for treating colorectal cancer

Country Status (22)

Country Link
US (2) US20130216493A1 (enExample)
EP (1) EP2635289B1 (enExample)
JP (1) JP5917537B2 (enExample)
KR (1) KR20130109171A (enExample)
CN (1) CN103313719A (enExample)
AR (1) AR083770A1 (enExample)
AU (1) AU2011324996B2 (enExample)
BE (1) BE1019494A3 (enExample)
BR (1) BR112013011012A2 (enExample)
CA (1) CA2816839A1 (enExample)
EA (1) EA201300540A1 (enExample)
ES (1) ES2401269B1 (enExample)
GB (1) GB201018650D0 (enExample)
MX (1) MX349690B (enExample)
MY (1) MY163067A (enExample)
NL (1) NL2007715C2 (enExample)
NZ (1) NZ611145A (enExample)
SG (1) SG189533A1 (enExample)
TW (1) TWI606832B (enExample)
UA (1) UA107998C2 (enExample)
WO (1) WO2012059725A1 (enExample)
ZA (1) ZA201304052B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
NZ743984A (en) 2012-09-11 2019-10-25 Norgine Bv Compositions comprising polyethylene glycol, alkali metal or alkaline earth metal sulphates and electrolytes for use as colon cleansing compositions
AR093153A1 (es) * 2012-10-26 2015-05-20 Northshore Univ Healthsystem Composiciones que comprenden polietilenglicol para la terapia del carcinoma de celulas escamosas de cabeza y cuello
CN103083733A (zh) * 2013-02-19 2013-05-08 华熙福瑞达生物医药有限公司 一种医用体腔器械导入水性润滑剂
CN113507933B (zh) * 2019-03-05 2024-05-10 陶氏环球技术有限责任公司 诱导胱天蛋白酶活性
CN113473996B (zh) 2019-03-05 2024-05-24 陶氏环球技术有限责任公司 诱导胱天蛋白酶活性
JP7487220B2 (ja) * 2019-03-05 2024-05-20 ダウ グローバル テクノロジーズ エルエルシー カスパーゼ活性を誘導するためのポリエチレングリコール誘導体

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010051659A1 (en) * 1998-10-27 2001-12-13 Denis Corpet Non-fermented osmotic laxative and method for treating and preventing colorectal cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US8457025B2 (en) * 2009-08-28 2013-06-04 Telefonaktiebolaget L M Ericsson (Publ) Method and network node for selecting a network prefix to be advertised in a communication network

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010051659A1 (en) * 1998-10-27 2001-12-13 Denis Corpet Non-fermented osmotic laxative and method for treating and preventing colorectal cancers

Also Published As

Publication number Publication date
EP2635289A1 (en) 2013-09-11
MX349690B (es) 2017-08-09
TW201304785A (zh) 2013-02-01
WO2012059725A8 (en) 2013-05-30
MX2013004963A (es) 2013-08-27
ES2401269A1 (es) 2013-04-18
AR083770A1 (es) 2013-03-20
CA2816839A1 (en) 2012-05-10
ES2401269B1 (es) 2014-02-19
CN103313719A (zh) 2013-09-18
ZA201304052B (en) 2014-02-26
UA107998C2 (uk) 2015-03-10
EA201300540A1 (ru) 2013-09-30
BE1019494A3 (fr) 2012-07-03
EP2635289B1 (en) 2020-03-11
TWI606832B (zh) 2017-12-01
WO2012059725A1 (en) 2012-05-10
JP2013544809A (ja) 2013-12-19
JP5917537B2 (ja) 2016-05-18
US20160228467A1 (en) 2016-08-11
BR112013011012A2 (pt) 2016-08-23
NL2007715A (en) 2012-05-07
SG189533A1 (en) 2013-05-31
KR20130109171A (ko) 2013-10-07
GB201018650D0 (en) 2010-12-22
AU2011324996A1 (en) 2013-05-02
NZ611145A (en) 2015-07-31
MY163067A (en) 2017-08-15
US20130216493A1 (en) 2013-08-22
NL2007715C2 (en) 2012-10-16

Similar Documents

Publication Publication Date Title
AU2011324996B2 (en) Peg or peg block copolymers for treating colorectal cancer
US9089528B2 (en) Liquid compositions of calcium acetate
AU2011324995B2 (en) Formulations comprising polyethylene glycol
JP2013540726A (ja) 便秘薬
IL225891A (en) Peg or block peg copolymers for the treatment of colorectal cancer
Patel Development of Novel Sustained Release Formulations for Older Adults With Swallowing Difficulties

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired